A Unique Comparison of Tooth Extraction Before and After Emicizumab Prophylaxis in a Patient With Haemophilia A and Inhibitors
Haemophilia A is an inherited X-linked bleeding disorder caused by Factor VIII deficiency; approximately 30% of the patients with haemophilia A develop inhibitors against Factor VIII. Emicizumab has been licenced for the prevention of bleeding in patients with haemophilia A with inhibitors and has d...
Saved in:
| Main Authors: | Miki Zaizen, Takahiro Yagyuu, Sachiko Yata, Hiroshi Nakamura, Mitsuhiko Imada, Nobuhiro Yamakawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Case Reports in Dentistry |
| Online Access: | http://dx.doi.org/10.1155/crid/8128415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PO44 | Emicizumab in acquired haemophilia A
Published: (2025-08-01) -
Severe haemophilia A with haemarthrosis improved on emicizumab: A case report
by: Wasifuddin Mustafa, et al.
Published: (2025-03-01) -
HINODE study: haemophilia A in infancy and newborns – protocol for a prospective, multicentre, observational study evaluating the coagulation potential and safety of emicizumab prophylaxis
by: Shouichi Ohga, et al.
Published: (2024-12-01) -
PO24 | Emicizumab prophylaxis and bleeding outcomes: a single center clinical experience
Published: (2025-08-01) -
Physical activity in patients with haemophilia - advantages and prophylaxis. Current trends
by: Patrycja Jędrzejewska-Rzezak
Published: (2025-05-01)